The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Apolipoprotein E: Structure-Function Relationships
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We identified Gly145Asp and Arg154Cys in the same J o u r n a l P r e -p r o o f region (amino acids ~ 148 to 168) [47]”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [47]
In the citing paper
“Variants predicted by models to be deleterious or being located near or in the receptor binding region (amino acids ~ 148 to 168) [47] could be suspected to pose ε2-like qualities.”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [47]
In the citing paper
“Additional support comes from the present data, where Gly145Asp and Arg154Cys are located in the receptor binding region (amino acids ≈148 to 168) 28 and display a phenotype similar to the ɛ2‐defining Arg176Cys residue with high apoE levels and seemingly low risk of dementia (no events).”
From APOE and dementia – resequencing and genotyping in 105,597 individuals (2020) · cites this paper as [28]
In the citing paper
“Val254Glu and Arg269Gly are located in the lipid‐binding carboxyl‐terminal domain (amino acids ≈243 to 317). 28 , 42”
From APOE and dementia – resequencing and genotyping in 105,597 individuals (2020) · cites this paper as [28]
In the citing paper
“However, the receptor-binding sites (AA136-150) for lipoprotein receptors such as the low-density lipoprotein receptor (LDLR), lipoprotein-related receptor 1 (LRP1), and heparan sulfate proteoglycans (HSPGs) are located in a region conserved between species (Fig. 1a) [11–14].”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“Notably, an HSPG and LDLR binding site in the APOE sequence is conserved in mice (blue boxed area, AA136-150), including arginine 136, which is replaced by serine in the Christchurch (Ch) variant [12, 39].”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“However, mAPOE and hAPOE have a conserved LDLR and HSPG binding motif between AA136 to 150 (human numbering) [11, 12, 39], which includes the R136S Christchurch variant.”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“The mature apoE protein consists of 299 amino acids and an 18amino acid signal peptide is removed post-translationally [17,28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“The APOE gene is located on chromosome 19 and consists of four exons [28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“Lipid-free apoE consists of two domains connected by a “hinge region”: the amino-terminal domain (amino acids 1 to 191) contains the receptor-binding function and the carboxyl-terminal domain (~amino acids 225 to 299) contains the lipid-binding function [28,33].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“The low density lipoprotein (LDL) receptor binding region is situated in helix four between amino acids 136 and 150 [17,28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“ApoE2 exhibits a lower affinity to the LDL receptor compared to apoE3: ~1% of the binding activity of apoE3 and apoE4 [28,36].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“Furthermore, apoE and apoB share the sequence with highest affinity for arterial proteoglycans, a key phenomenon for lipoprotein deposition in the arterial wall [28,63].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“ApoE contains two independently folded functional domains; these are a 22-kDa N-terminal domain (residues 1–191) and a 10-kDa C-terminal domain (residues 216–299) linked by a hinge region (18, 19).”
From Role of the N- and C-Terminal Domains in Binding of Apolipoprotein E Isoforms to Heparan Sulfate and Dermatan Sulfate: A Surface Plasmon Resonance Study (2008) · cites this paper as [18]
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
The Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins
Landschulz, W. H., Johnson, P. F., & McKnight, S. L. (1988) · Science · doi:10.1126/science.3289117 · Cited by 3,443
Prediction of protein conformation
Chou, P. Y., & Fasman, G. D. (1974) · Biochemistry · doi:10.1021/bi00699a002 · Cited by 3,309
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,396
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Research works printed but not linked: 17
- Cassel, 1984, Atherosclerosis (Shannon, Irel.), 52, 203
- Hallman, 1991, Am. J. Hum. Genet., 49, 338
- Havel, 1989, 1, 1129
- Koizumi, 1985, Antherosclerosis (Shannon, Irel.), 58, 175
- Landis, 1987, Am. J. Physiol., 252, G805
- Lund-Katz, 1993, J. Biol. Chem.
- Mahley, 1983, Arch. Pathol. Lab. Med., 107, 393
- Mahley, 1989, 1, 1195
- Mahley, 1983, 4, 151
- Mahley, 1977, Am. J. Pathol., 87, 205
- Mahley, 1983, Biochim. Biophys. Acta., 737, 197, 10.1016/0304-4157(83)90001-1 · DOI
- Mahley, 1989, 1, 1195
- Phillips, 1986, 128, 387
- Srinivasan, 1972, Atherosclerosis (Shannon, Irel.), 16, 95
- Utermann, 1980, Am. J. Hum. Genet., 32, 339
- Weisgraber, 1983, 4, 103
- Yamamura, 1984, Atherosclerosis (Shannon, Irel.), 50, 159
Cited by
Sorted by citations
Items 401–500 of 828
Isoform-specific effects of apoE on neurite outgrowth in olfactory epithelium culture
Hussain, A., Luong, M., Pooley, A., & Nathan, B. P. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-49 · Cited by 34
APOE Genotype Affects Outcome in a Murine Model of Sepsis: Implications for a New Treatment Strategy
Wang, H., Christensen, D. J., Vitek, M. P., Sullivan, P. M., & Laskowitz, D. T. (2009) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0903700111 · Cited by 34
Bates, K. A., Sohrabi, H. R., Rodrigues, M. A., Beilby, J. P., Dhaliwal, S. S., Taddei, K., Criddle, A., Wraith, M. J., Howard, M., Martins, G., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1050 · Cited by 36
Apolipoprotein E influences melatonin biosynthesis by regulating NAT and MAOA expression in C6 cells
Liu, Y., Meng, F., Wang, L., Zhang, L., Cheng, X., & Zhou, J. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00954.x · Cited by 35
ApolipoproteinE mimetic peptides improve outcome after focal ischemia
Wang, H., Anderson, L. G., Lascola, C. D., James, M. L., Venkatraman, T. N., Bennett, E. R., Acheson, S. K., Vitek, M. P., & Laskowitz, D. T. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.11.027 · Cited by 33
Johnson, L. A., Arbonés-Mainar, J. M., Fox, R. G., Pendse, A. A., Altenburg, M. K., Kim, H., & Maeda, N. (2011) · Diabetes · doi:10.2337/db11-0466 · Cited by 34
Weers, P. M. M., Narayanaswami, V., Choy, N., Luty, R., Hicks, L. D., Kay, C. M., & Ryan, R. O. (2002) · Biophysical Chemistry · doi:10.1016/s0301-4622(02)00300-9 · Cited by 33
Kim, S. H., Adhikari, B. B., Cruz, S., Schramm, M. P., Vinson, J. A., & Narayanaswami, V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135130 · Cited by 33
Chuang, S. T., Cruz, S., & Narayanaswami, V. (2020) · Nanomaterials · doi:10.3390/nano10050906 · Cited by 34
Matsunaga, A., & Saito, T. (2014) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0918-1 · Cited by 33
Kaufman, N. A., Beare, J. E., Tan, A. A., Vitek, M. P., McKenna, S., & Hoane, M. R. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.06.017 · Cited by 33
Smalinskienė, A., Petkevičienė, J., Lukšienė, D., Jurėnienė, K., Klumbienė, J., & Lesauskaitė, V. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-120 · Cited by 33
LDL Receptor's β-Propeller Displaces LDL
Innerarity, T. L. (2002) · Science · doi:10.1126/science.1080669 · Cited by 34
Goetz, F. W., Rise, M. L., Rise, M., Goetz, G., Binkowski, F. P., & Shepherd, B. S. (2009) · Physiological Genomics · doi:10.1152/physiolgenomics.00069.2009 · Cited by 33
Jansen, D., Zerbi, V., Janssen, C. I. F., van Rooij, D., Zinnhardt, B., Dederen, P. J. W. C., Wright, A. J., Broersen, L. M., Lütjohann, D., Heerschap, A., et al. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0606-7 · Cited by 35
Clément-Collin, V., Barbier, A., Dergunov, A. D., Visvikis, A., Siest, G., Desmadril, M., Takahashi, M., & Aggerbeck, L. P. (2006) · Biophysical Chemistry · doi:10.1016/j.bpc.2005.07.009 · Cited by 32
Hoffer, M. J. V., Niththyananthan, S., Naoumova, R. P., Kibirige, M. S., Frants, R. R., Havekes, L. M., & Thompson, G. R. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05819-4 · Cited by 32
Gupta, V., Narayanaswami, V., Budamagunta, M. S., Yamamato, T., Voss, J. C., & Ryan, R. O. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608085200 · Cited by 32
St‐Amand, J., Prud’homme, D., Moorjani, S., NADEAU, A., Tremblay, A., Bouchard, C., Lupien, P. J., & Després, J. (1999) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199905000-00011 · Cited by 32
Semenkovich, C. F., Goldberg, A. C., & Goldberg, I. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00037-7 · Cited by 32
Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice.
Hoshii, Y., Kawano, H., Cui, D., Takeda, T., Gondo, T., Takahashi, M., Kogishi, K., Higuchi, K., & Ishihara, T. (1997) · Europe PMC (PubMed Central) · Cited by 31
Gerdes, L. U., Vestergaard, P., Hermann, A. P., & Mosekilde, L. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.10.1906 · Cited by 31
Apolipoprotein E may be a critical factor in hormone therapy neuroprotection
Robert, G. S. (2008) · Frontiers in bioscience · doi:10.2741/3088 · Cited by 29
Degradation of Macrophage ApoE in a Nonlysosomal Compartment
Duan, H., Lin, C.-Y., & Mazzone, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.31156 · Cited by 31
Nguyen, D., Dhanasekaran, P., Nickel, M., Mizuguchi, C., Watanabe, M., Saito, H., Phillips, M. C., & Lund-Katz, S. (2014) · Biochemistry · doi:10.1021/bi500340z · Cited by 30
Matsuo, M., Campenot, R. B., Vance, D. E., Ueda, K., & Vance, J. E. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.10.004 · Cited by 31
Apolipoprotein E gene polymorphism in cerebrovascular disease: a case–controlstudy
Luthra, K., Prasad, K., Kumar, P., Dwivedi, M., Pandey, R., & Das, N. (2002) · Clinical Genetics · doi:10.1034/j.1399-0004.2002.620105.x · Cited by 30
Ren, B. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh039 · Cited by 31
Lipid-bound Structure of an Apolipoprotein E-derived Peptide
Raussens, V., Slupsky, C. M., Sykes, B. D., & Ryan, R. O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301753200 · Cited by 30
DeMattos, R. B., Thorngate, F. E., & Williams, D. L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02464.1999 · Cited by 30
In silico analyses of deleterious missense SNPs of human apolipoprotein E3
Pires, Á. S., Porto, W. F., Franco, O. L., & de Alencar, S. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-01737-w · Cited by 29
Apolipoprotein E mimetic peptide CN-105 improves outcome in a murine model of SAH
Liu, J., Zhou, G., Kolls, B. J., Tan, Y., Fang, C., Wang, H., & Laskowitz, D. T. (2018) · Stroke and Vascular Neurology · doi:10.1136/svn-2018-000152 · Cited by 29
Kacperczyk, M., Kmieciak, A., & Kratz, E. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137197 · Cited by 29
Common apolipoprotein E polymorphisms and risk of clinical malaria in the Gambia
Aucan, C., Walley, A. J., & Hill, A. V. S. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.011981 · Cited by 29
ApoE4-specific Misfolded Intermediate Identified by Molecular Dynamics Simulations
Williams, B., Convertino, M., Das, J., & Dokholyan, N. V. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004359 · Cited by 31
Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications
Portioli, C., Bovi, M., Benati, D., Donini, M., Perduca, M., Romeo, A., Dusi, S., Monaco, H. L., & Bentivoglio, M. (2016) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35961 · Cited by 31
Clinical chemistry of common apolipoprotein E isoforms
Dijck-Brouwer, J., van Doormaal, J. J., & Muskiet, F. A. J. (1996) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(95)00256-1 · Cited by 30
Cohn, J. S., Rodriguez, C., Jacques, H., Tremblay, M., & Davignon, J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.d300041-jlr200 · Cited by 31
Marques, M. A., Owens, P. A., & Crutcher, K. A. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:1:073 · Cited by 29
Tran, K. M., Kwang, N. E., Butler, C. A., Gomez-Arboledas, A., Kawauchi, S., Mar, C., Chao, D., Barahona, R. A., Da Cunha, C., Tsourmas, K. I., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00793-x · Cited by 28
Apolipoprotein Mimetic Peptides: An Emerging Therapy against Diabetic Inflammation and Dyslipidemia
Wolkowicz, P. E., White, C. R., & Anantharamaiah, G. M. (2021) · Biomolecules · doi:10.3390/biom11050627 · Cited by 29
Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?
Vecchio, F. L., Bisceglia, P., Imbimbo, B. P., Lozupone, M., Latino, R. R., Resta, E., Leone, M., Solfrizzi, V., Greco, A., Daniele, A., et al. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221081605 · Cited by 28
Fluoro-2-Deoxy-D-Glucose (FDG)-PET in APOEε4 Carriers in the Australian Population
Rimajova, M., Lenzo, N. P., Wu, J.-S., Bates, K. A., Campbell, A. M., Dhaliwal, S. S., McCarthy, M., Rodrigues, M. A., Paton, A., Rowe, C. C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13203 · Cited by 32
Saul, A., & Wirths, O. (2017) · Molecular Neurobiology · doi:10.1007/s12035-015-9674-4 · Cited by 28
Understanding Dengue Virus Capsid Protein Interaction with Key Biological Targets
Faustino, A. F., Martins, I. C., Carvalho, F. A., Castanho, M. A. R. B., Maurer‐Stroh, S., & Santos, N. C. (2015) · Scientific Reports · doi:10.1038/srep10592 · Cited by 28
Genes and atherosclerosis: at the origin of the predisposition
Puddu, P., Cravero, E., Puddu, G. M., & Muscari, A. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00439.x · Cited by 28
Dynamics and Hydration of the α-Helices of Apolipophorin III
Soulages, J. L., & Arrese, E. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909661199 · Cited by 28
The structure of human apolipoprotein E2, E3 and E4 in solution
Barbier, A., Clément‐Collin, V., Dergunov, A. D., Visvikis, A., Siest, G., & Aggerbeck, L. P. (2005) · Biophysical Chemistry · doi:10.1016/j.bpc.2005.07.010 · Cited by 28
Starck, M., Bertrand, P., P�pin, S., Schiele, F., Siest, G., & Galteau, M. M. (2000) · Cell Biochemistry and Function · doi:10.1002/(sici)1099-0844(200001/03)18:1 · Cited by 28
Hatters, D. M., Voss, J. C., Budamagunta, M. S., Newhouse, Y. N., & Weisgraber, K. H. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.12.040 · Cited by 28
Self-citationThe Role of ApoE in HCV Infection and Comorbidity
Gong, Y., & Cun, W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20082037 · Cited by 29
Influence of apolipoprotein E polymorphism on plasma vitamin A and vitamin E levels
Gómez‐Coronado, D., Bueno, A. E., Álvarez, J. J., Ortega, H., Olmos, J. M., Castro, M., Sastre, A., Herrera, E., & Lasunción, M. A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00983.x · Cited by 27
Intracellular lipid droplet targeting by apolipoprotein A-V requires the carboxyl-terminal segment
Shu, X., Ryan, R. O., & Forte, T. M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800111-jlr200 · Cited by 27
Yun, S. H., Park, K. A., Sullivan, P. M., Pasternak, J. F., LaDu, M. J., & Trommer, B. L. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20684 · Cited by 27
A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy
Hagiwara, M., Yamagata, K., Matsunaga, T., Arakawa, Y., Usui, J., Shimizu, Y., Aita, K., Nagata, M., Koyama, A., Zhang, B., et al. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm735 · Cited by 27
Impaired secretion of apolipoprotein E2 from macrophages
Fan, D., Qiu, S., Overton, C. D., Yancey, P. G., Swift, L. L., Jerome, W. G., Linton, M. F., & Fazio, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611754200 · Cited by 27
Moreno, J. A., Pérez‐Jiménez, F., Marı́n, C., Gómez, P., Pérez‐Martínez, P., Moreno‐Luna, R., Bellido, C., Fuentes, F. J., & López‐Miranda, J. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.5.1404 · Cited by 27
Dong, L., Innerarity, T. L., Arnold, K. S., Newhouse, Y. M., & Weisgraber, K. H. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32541-4 · Cited by 26
Self-citationFeatures of cholesterol structure that regulate the clearance of chylomicron-like lipid emulsions.
Mortimer, B.-C., Tso, P., Phan, C. T., Beveridge, D. J., Wen, J.-Y., & Redgrave, T. G. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41121-6 · Cited by 27
Influence of Western diet and APOE genotype on Alzheimer's disease risk
Sullivan, P. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104790 · Cited by 26
Wang, C., Yang, C., Yang, Y., Fu, P., He, L., & Wang, A. (2013) · Journal of Peptide Science · doi:10.1002/psc.2570 · Cited by 26
Tran, T. N., Kim, S. H., Gallo, C., Amaya, M., Kyees, J., & Narayanaswami, V. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.10.007 · Cited by 26
Tran, T. N., Kosaraju, M. G., Tamamizu‐Kato, S., Akintunde, O., Zheng, Y. Y., Bielicki, J. K., Pinkerton, K. E., Uchida, K., Lee, Y. Y., & Narayanaswami, V. (2013) · Biochemistry · doi:10.1021/bi401404u · Cited by 26
Cleavage and functional loss of human apolipoprotein E by digestion of matrix metalloproteinase‐14
Park, J. H., Park, S., Park, S., Cho, K., & Lee, S. (2008) · PROTEOMICS · doi:10.1002/pmic.200700487 · Cited by 25
NMR Structure and Dynamics of a Receptor-active Apolipoprotein E Peptide
Raussens, V., Slupsky, C. M., Ryan, R. O., & Sykes, B. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204043200 · Cited by 26
Wang, X.-S., Ciraolo, G. M., Morris, R., & Gruenstein, E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00877-9 · Cited by 26
Carboxyl-Terminal Domain of Human Apolipoprotein E: Expression, Purification, and Crystallization
Forstner, M., Peters-Libeu, C. A., Contreras-Forrest, E., Newhouse, Y. M., Knapp, M. S., Rupp, B., & Weisgraber, K. H. (1999) · Protein Expression and Purification · doi:10.1006/prep.1999.1144 · Cited by 26
Self-citationApolipoprotein E and Alzheimer's
BOCKXMEER, F. M. V. (1995) · Nature · doi:10.1038/375285b0 · Cited by 27
Günaydin, C., Sondhi, D., Kaminsky, S. M., Lephart, H. C., Leopold, P. L., Hackett, N. R., Khanna, R., & Crystal, R. G. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.11.003 · Cited by 26
Yamamura, T., Dong, L.-M., & Yamamoto, A. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33364-2 · Cited by 25
Anantharamaiah, G. M., Garber, D. W., Goldberg, D., Morrel, E. M., Datta, G., Palgunachari, M. N., Register, T. C., Appt, S. E., & White, C. R. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m085985 · Cited by 25
Olivecrona, M., Wildemyr, Z., & Koskinen, L. (2009) · Journal of neurosurgery · doi:10.3171/2009.8.jns09636 · Cited by 26
Nayyar, G., Handattu, S. P., Monroe, C. E., Chaddha, M., Datta, G., Mishra, V., Keenum, T. D., Palgunachari, M. N., Garber, D. W., & Anantharamaiah, G. M. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.09.030 · Cited by 25
Prévost, M., & Raussens, V. (2004) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20080 · Cited by 25
Long-term effects of estradiol replacement in the olfactory system
Nathan, B. P., Tonsor, M., & Struble, R. G. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.001 · Cited by 25
Ferreira, S., Dupire, M.-J., Delacourte, A., Najïb, J., & Caillet‐Boudin, M. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7510 · Cited by 25
Woody, S. K., Zhou, H., Ibrahimi, S., Dong, Y., & Zhao, L. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160307 · Cited by 23
He, K., Nie, L., Zhou, Q., Rahman, S. U., Liu, J., Yang, X., & Li, S. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00136 · Cited by 24
Interaction of serum proteins with SARS-CoV-2 RBD
Yin, Y., Sheng, Y.-J., Wang, M., Ma, Y., & Ding, H. (2021) · Nanoscale · doi:10.1039/d1nr02687a · Cited by 22
Apolipoprotein E Genotype and Early Alzheimer's Disease: A Longitudinal SPECT Study
Sakamoto, S., Matsuda, H., Asada, T., Ohnishi, T., Nakano, S., Kanetaka, H., & Takasaki, M. (2003) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2003.tb00167.x · Cited by 24
Brain area- and isoform-specific inhibition of synaptic plasticity by apoE4
Levi, O., Jongen‐Rêlo, A. L., Feldon, J., & Michaelson, D. M. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.035 · Cited by 23
Kothapalli, D., Castagnino, P. A., Rader, D. J., Phillips, M. C., Lund‐Katz, S., & Assoian, R. K. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.12.003 · Cited by 24
Kara, E., Marks, J. D., Fan, Z., Klickstein, J. A., Roe, A. D., Krogh, K. A., Wegmann, S., Maesako, M., Luo, C. C., Mylvaganam, R., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.784264 · Cited by 23
Inhibition of c-Jun N-terminal kinase increases apoE expression in vitro and in vivo
Pocivavsek, A., & Rebeck, G. W. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.048 · Cited by 24
Hauser, P. S., & Ryan, R. O. (2007) · Protein Expression and Purification · doi:10.1016/j.pep.2007.04.002 · Cited by 24
Structure-guided Protein Engineering Modulates Helix Bundle Exchangeable Apolipoprotein Properties
Kiss, R. S., Weers, P. M. M., Narayanaswami, V., Cohen, J. K., Kay, C. M., & Ryan, R. O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302676200 · Cited by 24
Golabek, A. A., Kida, E., Walus, M., Perez, C., Wısnıewskı, T., & Soto, C. A. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76354-5 · Cited by 24
(2004) · doi:10.1016/j.bbalip.2004.03.004 · Cited by 17
Soulages, J. L., Arrese, E. L., Chetty, P. S., & Rodriguez, V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105836200 · Cited by 24
Skropeta, D., Settasatian, C., McMahon, M., Shearston, K., Caiazza, D., McGrath, K. C. Y., Jin, W., Rader, D. J., Barter, P. J., & Rye, K. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700248-jlr200 · Cited by 24
Pearson, K. J., Tubb, M. R., Tanaka, M., Zhang, X. Q., Tso, P., Weinberg, R. B., & Davidson, W. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506802200 · Cited by 24
Chuang, S. T., Shon, Y., & Narayanaswami, V. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s145326 · Cited by 24
Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E
Li, Z., Li, Y., Bi, Y., Zhang, H., Yao, Y., Li, Q., Cun, W., & Dong, S. (2017) · Journal of Virology · doi:10.1128/jvi.02227-16 · Cited by 23
Atomistic Insights into Structural Differences between E3 and E4 Isoforms of Apolipoprotein E
Ray, A., Ahalawat, N., & Mondal, J. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.10.006 · Cited by 23
Structural differences between apolipoprotein E3 and E4 as measured by 19F NMR
Garai, K., Mustafi, S. M., Baban, B. A., & Frieden, C. (2009) · Protein Science · doi:10.1002/pro.283 · Cited by 23
St‐Amand, J., Moorjani, S., Lupien, P. J., Prud’homme, D., & Després, J. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90064-5 · Cited by 23
Apolipoprotein E Recognizes Alzheimer's Disease Associated 3‐O Sulfation of Heparan Sulfate
Mah, D., Zhu, Y., Su, G., Zhao, J., Canning, A., Gibson, J. M., Song, X., Stancanelli, E., Xu, Y., Zhang, F., et al. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202212636 · Cited by 26
APOE and vascular disease: Sequencing and genotyping in general population cohorts
Rasmussen, K. L., Luo, J., Nordestgaard, B. G., Tybjærg-Hansen, A., & Frikke-Schmidt, R. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117218 · Cited by 22
Fluorescence Analysis of the Lipid Binding-Induced Conformational Change of Apolipoprotein E4
Mizuguchi, C., Hata, M., Dhanasekaran, P., Nickel, M., Phillips, M. C., Lund‐Katz, S., & Saito, H. (2012) · Biochemistry · doi:10.1021/bi300672s · Cited by 21
Zhang, F. L. Y. P. (2013) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.s12-010 · Cited by 22
Metadata
- Authors
- Weisgraber, K. H.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Weisgraber, Karl H.
- Venue
- Advances in Protein Chemistry
- Publisher
- Elsevier
- Published
- 1994
- Volume
- 45
- Pages
- 249-302
- ISSN
- 0065-3233 (ISSN-L)
- OpenAlex
- W98152484
- Cited by
- 830
- References
- 194
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 14 · 2023: 17 · 2022: 12 · 2021: 20 · 2020: 12 · 2019: 13 · 2018: 14 · 2017: 20 · 2016: 18 · 2015: 15 · 2014: 18 · 2013: 23 · 2012: 26
- FWCI
- 89.45
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Advances in protein chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL-41633, P01HL041633)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- apolipoprotein E, lipoprotein metabolism, apolipoprotein structure, APOE isoforms, lipid transfer proteins, lipoprotein receptors, triglyceride-rich lipoproteins, reverse cholesterol transport, lipolysis, serum lipoproteins
- MeSH terms
- Amino Acid Sequence, Animals, Apolipoproteins E, Humans, Molecular Sequence Data, Protein Conformation, Structure-Activity Relationship, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
